Eisai, Takeda Report Losses Due to Acquisitions; Daiichi Sankyo Reports Earnings Lower Because Of NHI Drug Pricing

TOKYO - Top Japanese pharmaceutical manufacturers July 31 reported mixed earnings results for their latest reporting periods, reflecting the costs of acquisitions and reductions in Japan's national health insurance drug pricing